AML M5
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Clinical Study of Anti-ILT3 CAR-T Therapy for R/R AML(M4/M5) (NCT04803929) | Carbiogene Therapeutics Co. Ltd. | 2021-03-03 |
Track AML M5 automatically
Every clearance here is in the API, with alerts when new ones post.